Proceedings of the 1st Symposium "Autoimmune Diseases: Clinical Unmet Needs in Systemic Autoimmune Diseases Guide Clinical, Translational and Basic Research"

Overview

Journal Mediterr J Rheumatol

Date 2025 Jan 31

PMID 39886294

Authors

Loukas Chatzis

Alexandra Koutsogianni

Panagiota Palla

Dimitrios Palamidas

Panagiotis Panagopoulos

Papadaki Maria

Evangelos Andreakos

Athanasios G Tzioufas

Affiliations

Soon will be listed here.

References

Hellmich B, Sanchez-Alamo B, Schirmer J, Berti A, Blockmans D, Cid M . EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2023; 83(1):30-47. DOI: 10.1136/ard-2022-223764. View

Summers G, Metsios G, Stavropoulos-Kalinoglou A, Kitas G . Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol. 2010; 6(8):445-51. DOI: 10.1038/nrrheum.2010.105. View

Xu D, Tang L, Wang Y, Pan J, Su C . LC-MS-based rheumatoid arthritis serum metabolomics reveals the role of deoxyinosine in attenuating collagen-induced arthritis in mice. Heliyon. 2024; 10(10):e30903. PMC: 11108858. DOI: 10.1016/j.heliyon.2024.e30903. View

Siouti E, Salagianni M, Manioudaki M, Pavlos E, Klinakis A, Galani I . Notch signaling in adipose tissue macrophages prevents diet-induced inflammation and metabolic dysregulation. Eur J Immunol. 2024; 54(5):e2350669. DOI: 10.1002/eji.202350669. View

Feldmann M, Maini R . Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat Med. 2003; 9(10):1245-50. DOI: 10.1038/nm939. View

Aringer M, Petri M . New classification criteria for systemic lupus erythematosus. Curr Opin Rheumatol. 2020; 32(6):590-596. PMC: 8020886. DOI: 10.1097/BOR.0000000000000740. View

Fisher B, Mariette X, Papas A, Grader-Beck T, Bootsma H, Ng W . Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study. Lancet. 2024; 404(10452):540-553. DOI: 10.1016/S0140-6736(24)01211-X. View

Katechis S, Nikolopoulos D, Flouda S, Adamichou C, Chavatza K, Kapsala N . Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation. Rheumatology (Oxford). 2024; . DOI: 10.1093/rheumatology/keae278. View

Apostolidou E, Skendros P, Kambas K, Mitroulis I, Konstantinidis T, Chrysanthopoulou A . Neutrophil extracellular traps regulate IL-1β-mediated inflammation in familial Mediterranean fever. Ann Rheum Dis. 2014; 75(1):269-77. DOI: 10.1136/annrheumdis-2014-205958. View

10.

Dorner T, Kaul M, Szanto A, Tseng J, Papas A, Pylvaenaeinen I . Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial. Ann Rheum Dis. 2023; 83(3):360-371. PMC: 10894844. DOI: 10.1136/ard-2023-224691. View

11.

Hakkim A, Furnrohr B, Amann K, Laube B, Abu Abed U, Brinkmann V . Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A. 2010; 107(21):9813-8. PMC: 2906830. DOI: 10.1073/pnas.0909927107. View

12.

Palamidas D, Chatzis L, Papadaki M, Gissis I, Kambas K, Andreakos E . Current Insights into Tissue Injury of Giant Cell Arteritis: From Acute Inflammatory Responses towards Inappropriate Tissue Remodeling. Cells. 2024; 13(5. PMC: 10930978. DOI: 10.3390/cells13050430. View

13.

Hemann E, Gale Jr M, Savan R . Interferon Lambda Genetics and Biology in Regulation of Viral Control. Front Immunol. 2017; 8:1707. PMC: 5723907. DOI: 10.3389/fimmu.2017.01707. View

14.

Chrysanthopoulou A, Kambas K, Stakos D, Mitroulis I, Mitsios A, Vidali V . Interferon lambda1/IL-29 and inorganic polyphosphate are novel regulators of neutrophil-driven thromboinflammation. J Pathol. 2017; 243(1):111-122. DOI: 10.1002/path.4935. View

15.

Al Sawah S, Zhang X, Zhu B, Magder L, Foster S, Iikuni N . Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins Lupus Cohort. Lupus Sci Med. 2015; 2(1):e000066. PMC: 4378372. DOI: 10.1136/lupus-2014-000066. View

16.

De Vita S, Isola M, Baldini C, Goules A, Chatzis L, Quartuccio L . Predicting lymphoma in Sjögren's syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording. Rheumatology (Oxford). 2022; 62(4):1586-1593. PMC: 10072883. DOI: 10.1093/rheumatology/keac470. View

17.

Narvaez J, Aburto M, Seoane-Mato D, Bonilla G, Acosta O, Candelas G . Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology. Reumatol Clin (Engl Ed). 2022; 19(2):74-81. DOI: 10.1016/j.reumae.2021.12.003. View

18.

Mackensen A, Muller F, Mougiakakos D, Boltz S, Wilhelm A, Aigner M . Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat Med. 2022; 28(10):2124-2132. DOI: 10.1038/s41591-022-02017-5. View

19.

Mehta N, Yu Y, Saboury B, Foroughi N, Krishnamoorthy P, Raper A . Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Arch Dermatol. 2011; 147(9):1031-9. PMC: 3158301. DOI: 10.1001/archdermatol.2011.119. View

20.

Fang C, Du L, Gao S, Chen Y, Chen Z, Wu Z . Association between premature vascular smooth muscle cells senescence and vascular inflammation in Takayasu's arteritis. Ann Rheum Dis. 2024; 83(11):1522-1535. PMC: 11503059. DOI: 10.1136/ard-2024-225630. View